Cellectis Provides Business Updates and Preliminary Financial Results for Second Quarter 2023
Updated clinical & translational data on BALLI-01 trial (evaluating UCART22 in r/r B-cell ALL) presented at…
Month: August 2023
Cellectis Provides Business Updates and Preliminary Financial Results for Second Quarter 2023
Updated clinical & translational data on BALLI-01 trial (evaluating UCART22 in r/r B-cell ALL) presented at…
Praxis Precision Medicines to Participate at the 2023 Wedbush PacGrow Healthcare Conference
BOSTON, Aug. 03, 2023 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
Praxis Precision Medicines to Participate at the 2023 Wedbush PacGrow Healthcare Conference
BOSTON, Aug. 03, 2023 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
IGM Biosciences Announces Second Quarter 2023 Financial Results
– Continued progress in clinical development across portfolio –– Public equity offering and concurrent private…
IGM Biosciences Announces Second Quarter 2023 Financial Results
– Continued progress in clinical development across portfolio –– Public equity offering and concurrent private…
Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology…
Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology…
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
– Phase 2 data readouts from ongoing chronic hepatitis B and chronic hepatitis delta programs…
Revolution Medicines to Report Financial Results for Second Quarter 2023 After Market Close on August 8, 2023
REDWOOD CITY, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
Sana Biotechnology Reports Second Quarter 2023 Financial Results and Business Updates
Enrolling patients in ARDENT, the SC291 Phase 1 clinical trial in B-cell malignancies, with initial…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Party City Holdco Inc. (PRTY, PRTYQ) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Myriad Genetics Reports Second Quarter 2023 Financial Results and Reaffirms 2023 Revenue and Adjusted EPS Guidance; Generates the Fourth Consecutive Quarter of Double-Digit Year-Over-Year Testing Volume Growth
Highlights: Second quarter testing volume grew 17% year-over-year, excluding contributions from the SneakPeek® Early Gender…
Xilio Therapeutics Announces Promotion of Chris Frankenfield to Chief Operating Officer
WALTHAM, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology…
Codexis Reports Second Quarter 2023 Financial Results
Company Recently Announced Enhanced Strategic Focus and Portfolio Prioritization Anticipate Demonstrating Gram-Scale Synthesis of ECO…
NextCure Provides Business Update and Reports Second Quarter 2023 Financial Results
Phase 1b data for NC410 and further updates on other clinical programs expected in the…
Kura Oncology Reports Second Quarter 2023 Financial Results
– Enrollment in registration-directed trial of ziftomenib in NPM1-mutant AML continues to outperform projections –…
CymaBay Therapeutics to Report Second Quarter of 2023 Financial Results on Thursday, August 10, 2023
NEWARK, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage…
Cleantek Industries Inc. Announces 2023 Q2 Results
Calgary, Alberta–(Newsfile Corp. – August 3, 2023) – Cleantek Industries Inc. (TSXV: CTEK) (“Cleantek” or…
WhiteBIT Crypto Exchange Has Launched Its Own Blockchain
Vilnius, Lithuania–(Newsfile Corp. – August 3, 2023) – In August of this year, the WhiteBIT…